Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IXICO PLC Remuneration Information 2014

Oct 29, 2014

7723_dirs_2014-10-29_14494ce2-c37c-4c62-bf2b-6085cacd7669.html

Remuneration Information

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 5267V

IXICO plc

29 October 2014

IXICO plc

Grant of Awards to Directors under Long-Term Incentive Plan

IXICO plc (AIM: IXI) the brain health company (hereafter the "Company"), today announces that on 28 October 2014 the Remuneration Committee agreed to grant options to the Company's Executive Directors under the rules of the Company's EMI Share Option Plan 2014 (hereafter the "Scheme").

The award of options under the Scheme are over the ordinary shares in the Company and are exercisable at an exercise price of 49.0p subject to various conditions. For each Executive Director, half of the options will not vest earlier than one year from the date of grant and such vesting will be subject to absolute share price performance.  The options will vest in equal tranches on the first, second the third anniversary of grant with an annual hurdle of 10% share price appreciation being required in any 12 month period. The other half of the options are subject to a number of enhanced performance criteria including a more than doubling of the share price in a twelve month period or other corporate and strategic goals being met.

The total number of options being issued under at this time is 1,144,470. The following table sets out the details of the options that have been granted to the Executive Directors:

Name of Director Number of options granted over ordinary shares Percentage of issued shares under option
Derek Hill 180,706 1.2%
Charles Spicer 150,588 1.0%
Susan Lowther 150,588 1.0%
Total 481,882 3.2%

For further information please contact:

Enquiries:                                    

IXICO plc                               

Derek Hill, CEO

Charles Spicer, VP Corporate Development                         

+44 20 3763 7499

Peel Hunt LLP (Nominated Adviser and Broker)

James Steel

Clare Terlouw

+44 20 7418 8900

Daniel Stewart & Company (Joint Broker)

Mark Treharne

David Hart

+44 207 776 6550

FTI Consulting Limited (Investor Relations)

Simon Conway

John Dineen

+44 20 3727 1000

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSGMMZGNRLGDZM